This clinical case describes a double valve surgery in a 58-year-old female patient with Scheie's syndrome, and considers treatment options for symptoms of this rare condition.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease
September 12, 2016
The presence of a bicuspid valve has been considered as a relative contraindication for transcatheter aortic valve implantation (TAVI). This a multicentre retrospective study of 51 patients with bicuspid aortic stenosis who had undergone TAVI using a next-generation transcatheter heart valve (Edwards SAPIEN 3). 30- day mortality was 3,9%.
September 7, 2016
This multistudy registry, entitled ROUTE, studied the effectiveness and safety of transaortic access for TAVI in 301 patients. Mean age was 82 years and mean STS Score 9.0. Valve success was 97%.
September 6, 2016
In this retrospective review of 460 consecutive patients undergoing transcatheter aortic valve implantation with the Edwards Sapiens XT or Sapiens 3 prosthesis, the authors analyse the incidence, clinical implications and predisposing factors related to trancatheter heart valve (THV) thrombosis.
August 29, 2016
This video depicts a minimally invasive aortic valve replacement via a right anterolateral mini-thoracotomy, using the Edwards Intuity rapid deployment aortic valve system, in a 75-year-old male patient with severe aortic stenosis.
August 25, 2016
Vinnie Bapat of Guy’s and St. Thomas’ NHS Foundation Trust, London, UK, discusses the development of a minimally invasive aortic valve replacement program at his institution.
August 24, 2016
This single-center retrospective study evaluated outcomes of ESRD patients undergoing valve surgery based on whether they received either a mechanical or tissue valve. The study spanned the years 2002-2014, and included 64 mechanical and 151 tissue valve replacements.
August 9, 2016
In this study the investigators aimed to study whether a cerebral protection device during TAVI reduced the number of cerebral lesions in patients undergoing TAVI.
July 28, 2016
Filmed at the 2016 STS Annual Meeting in Phoenix, Arizona, a group of experts discuss the future of aortic stenosis treatment.
July 14, 2016
This article explores the controversial topic of TAVR versus surgical AVR in low-risk patients. The primary outcome was 3-year survival. The authors report 3-year survival for TAVR and surgical AVR as 72% and 83.4%, respective (p=0.0015). Although TAVR is an exciting technology, there should be caution in adopting it in lower risk patients.